Dyskerin(DKC1), a core-component of the telomerase holoenzyme is typically overexpressed in breast and prostate cancers [146, 147], whereas its expression is often reduced in endometrial carcinoma and pituitary tumors [148, 149]. This evidence concerns the gene DKC1 and prostate carcinoma.